CS
China Shineway Pharmaceutical Group Limited
CSWYF · OTC
$1.00 +0.00% (+$0.00)
Market Cap ¥5.07B
P/E Ratio 5.34x
Div. Yield 18.05%
ROE 12.39%
Bulios Fair Price
$1.41
40.4% upside
Current Price
$1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CSWYF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
98 /100
Cheap P/E 5.34x
P/S 1.62x
P/B 0.63x
Growth
28 /100
Declining EPS growth 9.49%
Rev. growth 8.02%
FCF growth 3.72%
Profitability
98 /100
Strong Gross margin 72.28%
Net margin 30.30%
Op. margin 22.89%
Quality
46 /100
Average ROIC 6.25%
ROE 12.39%
ROA 8.81%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 3.71x
Int. coverage 224.27x
Stability
64 /100
Moderate Beta 0.72x
Rev. volatility 432.52%
EPS volatility 23.39%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CSWYF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Zhenjiang Li
Employees
2,822
Headquarters
Shijiazhuang